From the Chicago Tribune
"This is just the beginning and we don't really know exactly what it means," said Dr. Evan Snyder of Harvard Medical School and Boston Children's Hospital, who discovered brain stem cells 15 years ago, the first such cells to be found in a solid organ. "There's an enormous amount of work to be done to prove that we're not simply being fooled by things we see in tissue cultures."
But Snyder's discovery appears to shatter a major tenet of biology--that once nature created an organism, the blueprint was...
By Rebecca Palmer
Deseret News
Published: Sunday, Aug. 3, 2008 12:18 a.m. MDT
Four years ago, Maggie Anderson's spine was crushed when the minivan she was riding in hit black ice, flipped and landed on her.
Anderson will forever regret not strapping on a seat belt that day in Idaho. But at 21, she's found joy in life, good friends and even a chance of escaping her wheelchair.
Hope first came days after the crash, when she realized she could roll over. Three years later, after intensive daily ...
Washington, July 25 (IANS) Adult stem cells actually originate in a different part of the brain unlike previously believed and can be coaxed into producing new brain cells to replace those lost to disease or...
TUESDAY, July 22 (HealthDay News) -- Adult stem cells that may prove valuable in efforts to develop nonsurgical treatments for spinal cord injuries have been identified by researchers in the United States and...
Eight years ago a Swedish medical registrar, Anna Bagenholm, found herself the subject of the medical textbooks she had been studying. Skiing with friends in a waterfall gully in northern Norway, she went off course and plunged head-first into the...
NEW YORK & PETACH TIKVAH, Israel, Jul 07, 2008 (BUSINESS WIRE) ----BrainStorm Cell Therapeutics Inc. (OTCBB:BCLI), a leading developer of adult stem cell technologies and therapeutics, has completed a preclinical study in collaboration with the W.M. Keck Center for Collaborative Neuroscience at Rutgers, The State University of New Jersey. The study ...
EU-funded scientists have forced damaged nerve cells to regenerate by administering a drug commonly used to treat cancer. The findings could one day lead to the development of effective treatments for injuries to the...
A tiny start-up company in Irvine has a shot at becoming the first to gain federal approval to test an embryonic stem cell treatment in humans. Two degenerative nerve diseases are the first targets for California Stem Cell Inc.'s therapies. They are ALS, or Lou Gehrig's Disease, which kills adults, and...
CLEVELAND, June 18 /PRNewswire/ -- Synapse Biomedical Inc. announced today it has received approval from the U.S. Food and Drug Administration (FDA) for its NeuRx DPS(TM) for ventilator-dependent Spinal Cord Injury (SCI) patients who lack voluntary control of their diaphragms. With the FDA's approval, SCI patients and their caregivers...
MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) today announced the presentation of research studies indicating that GRNCM1, the company’s human embryonic stem cell (hESC)-based therapeutic for the treatment of heart failure, evades direct attack by...